FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

James Brooks

Research Profile

Disorders

Devices

Oligonucleotide Array Sequence Analysis

Procedures

Physiology

Gene Expression Regulation, Neoplastic

Anatomy

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
James D Brooks
Epigenetic changes in histologically normal prostate tissues.
Bo Wu; Debashis Sahoo; James D Brooks
Comprehensive gene expression changes associated with mouse postnatal kidney development.
Z G Gulzar; Jesse K McKenney; James D Brooks
Increased expression of NuSAP in recurrent prostate cancer is mediated by E2F1.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of James Brooks (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: James D Brooks
Epigenetic changes in histologically normal prostate tissues.
The Journal of urology 2013;189(6):2020-1.
2013: Bo Wu; Debashis Sahoo; James D Brooks
Comprehensive gene expression changes associated with mouse postnatal kidney development.
The Journal of urology 2013;189(6):2385-90.
2013: Z G Gulzar; Jesse K McKenney; James D Brooks
Increased expression of NuSAP in recurrent prostate cancer is mediated by E2F1.
Oncogene 2013;32(1):70-7.
2012: S Huang; Jacques Lapointe; James D Brooks; Z G Gulzar; Keyan Salari; Jonathan R Pollack
Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness.
Oncogene 2012;31(37):4164-70.
2012: Bo Wu; James D Brooks
Gene expression changes induced by unilateral ureteral obstruction in mice.
The Journal of urology 2012;188(3):1033-41.
2008: Maxwell Thompson; Jacques Lapointe; Yoon L. Choi; David E Ong; John P Higgins; James D Brooks; Jonathan R Pollack
Identification of candidate prostate cancer genes through comparative expression-profiling of seminal vesicle.
The Prostate 2008;68(11):1248-56.
2008: Christopher R King; Joseph C Presti; James D Brooks; Harcharan Gill; Michael T Spiotto
Postoperative prostate-specific antigen velocity independently predicts for failure of salvage radiotherapy after prostatectomy.
International journal of radiation oncology, biology, physics 2008;70(5):1472-7.
2008: Jacques Lapointe; Sameer Malhotra; John P Higgins; Eric Bair; Maxwell Thompson; Keyan Salari; Craig P Giacomini; Michelle Ferrari; Kelli Montgomery; Robert Tibshirani; Matt van de Rijn; James D Brooks; Jonathan R Pollack
hCAP-D3 expression marks a prostate cancer subtype with favorable clinical behavior and androgen signaling signature.
The American journal of surgical pathology 2008;32(2):205-9.
2007: Jacques Lapointe; Chunde Li; Craig P Giacomini; Keyan Salari; Stephanie Huang; Pei Wang; Michelle Ferrari; Tina Hernandez-Boussard; James D Brooks; Jonathan R Pollack
Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis.
Cancer research 2007;67(18):8504-10.
2007: John P Higgins; Gulsah Kaygusuz; Lingli Wang; Kelli Montgomery; Veronica Mason; Shirley X Zhu; Robert J Marinelli; Joseph C Presti; Matt van de Rijn; James D Brooks
Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
The American journal of surgical pathology 2007;31(5):673-80.
2007: Jacques Lapointe; Young H Kim; Melinda A Miller; Chunde Li; Gulsah Kaygusuz; Matt van de Rijn; David Huntsman; James D Brooks; Jonathan R Pollack
A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosis.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2007;20(4):467-73.
2007: Hongjuan Zhao; James D Brooks
Selenomethionine induced transcriptional programs in human prostate cancer cells.
The Journal of urology 2007;177(2):743-50.
2007: Paul-Martin Holterhus; Uta Deppe; Ralf Werner; Annette Richter-Unruh; Jan-Hendrik Bebermeier; Lutz Wünsch; Susanne Krege; Hans-Udo Schweikert; Janos Demeter; Felix Riepe; Olaf Hiort; James D Brooks
Intrinsic androgen-dependent gene expression patterns revealed by comparison of genital fibroblasts from normal males and individuals with complete and partial androgen insensitivity syndrome.
BMC genomics 2007;8():376.
2007: Tzu-Huey Li; Hongjuan Zhao; Yue Peng; Jason Beliakoff; James D Brooks; Zijie Sun
A promoting role of androgen receptor in androgen-sensitive and -insensitive prostate cancer cells.
Nucleic acids research 2007;35(8):2767-76.
2007: Hongjuan Zhao; Cristiane F Ramos; James D Brooks; Donna M Peehl
Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues.
Journal of cellular physiology 2007;210(1):111-21.
2006: Jan-Hendrik Bebermeier; James D Brooks; Samuel E DePrimo; Ralf Werner; Uta Deppe; Janos Demeter; Olaf Hiort; Paul-Martin Holterhus
Cell-line and tissue-specific signatures of androgen receptor-coregulator transcription.
Journal of molecular medicine (Berlin, Germany) 2006;84(11):919-31.
2006: Christopher R King; John E McNeal; Harcharan Gill; James D Brooks; Sandy Srinivas; Joseph C Presti
Reliability of small amounts of cancer in prostate biopsies to reveal pathologic grade.
Urology 2006;67(6):1229-34.
2006: Jian F Ma; Steven E Coutre; Myriam J Curet; James D Brooks
Refractory hematuria from amyloidosis successfully treated by splenectomy.
Urology 2006;67(5):1085.e13-5.
2006: Shijun Li; Suvarna Bhamre; Jacques Lapointe; Jonathan R Pollack; James D Brooks
Application of genomic technologies to human prostate cancer.
Omics : a journal of integrative biology 2006;10(3):261-75.
2006: Sunita B Jones; James D Brooks
Modest induction of phase 2 enzyme activity in the F-344 rat prostate.
BMC cancer 2006;6():62.
2006: Hongjuan Zhao; Börje Ljungberg; Kjell Grankvist; Torgny Rasmuson; Robert Tibshirani; James D Brooks
Gene expression profiling predicts survival in conventional renal cell carcinoma.
PLoS medicine 2006;3(1):e13.
2005: Hanna Kim; Jacques Lapointe; Gulsah Kaygusuz; David E Ong; Chunde Li; Matt van de Rijn; James D Brooks; Jonathan R Pollack
The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer.
Cancer research 2005;65(18):8118-24.
2005: Deep A Patel; Joseph C Presti; John E McNeal; Harcharan Gill; James D Brooks; Christopher R King
Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(25):6157-62.
2005: Hongjuan Zhao; Young Kim; Pei Wang; Jacques Lapointe; Robert Tibshirani; Jonathan R Pollack; James D Brooks
Genome-wide characterization of gene expression variations and DNA copy number changes in prostate cancer cell lines.
The Prostate 2005;63(2):187-97.
2005: Jeffrey B Marotte; James D Brooks; Daniel Y Sze; William A Kennedy
Juvenile posttraumatic high-flow priapism: current management dilemmas.
Journal of pediatric surgery 2005;40(4):E25-8.
2005: Zhennan Gu; Mark A Rubin; Yu Yang; Samuel E DePrimo; Hongjuan Zhao; Steven Horvath; James D Brooks; Massimo Loda; Robert E Reiter
Reg IV: a promising marker of hormone refractory metastatic prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(6):2237-43.
2005: Sunita B Jones; Samuel E DePrimo; Michael L Whitfield; James D Brooks
Resveratrol-induced gene expression profiles in human prostate cancer cells.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(3):596-604.
2005: Hongjuan Zhao; Frank Lai; Larisa Nonn; James D Brooks; Donna M Peehl
Molecular targets of doxazosin in human prostatic stromal cells.
The Prostate 2005;62(4):400-10.
2005: Keith L Lee; Jeffrey B Marotte; Michelle K Ferrari; John E McNeal; James D Brooks; Joseph C Presti
Positive family history of prostate cancer not associated with worse outcomes after radical prostatectomy.
Urology 2005;65(2):311-5.
2004: Donna M Peehl; Rajesh Shinghal; Larisa Nonn; Eugene Seto; Aruna V Krishnan; James D Brooks; David Feldman
Molecular activity of 1,25-dihydroxyvitamin D3 in primary cultures of human prostatic epithelial cells revealed by cDNA microarray analysis.
The Journal of steroid biochemistry and molecular biology 2004;92(3):131-41.
2004: Michelle K Ferrari; John E McNeal; Sameer M Malhotra; James D Brooks
Vascular invasion predicts recurrence after radical prostatectomy: stratification of risk based on pathologic variables.
Urology 2004;64(4):749-53.
2004: Joseph C Presti; Una Lee; James D Brooks; Martha Kennedy Terris
Lower body mass index is associated with a higher prostate cancer detection rate and less favorable pathological features in a biopsy population.
The Journal of urology 2004;171(6 Pt 1):2199-202.
2004: Aruna V Krishnan; Rajesh Shinghal; Nalini Raghavachari; James D Brooks; Donna M Peehl; David Feldman
Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays.
The Prostate 2004;59(3):243-51.
2004: Jeffrey B Marotte; Michelle K Ferrari; John E McNeal; James D Brooks; Joseph C Presti
Time trends in pathologic features of radical prostatectomy--impact of family history.
Urologic oncology 2004;22(3):169-73.
2004: Debby H Chao; John P Higgins; James D Brooks
Biochemical remission after resection of prostate cancer lung metastasis.
Urology 2004;63(3):584-5.
2004: John P Higgins; Lingli Wang; Neeraja Kambham; Kelli Montgomery; Veronica Mason; Stefanie U Vogelmann; Kevin V Lemley; Patrick O Brown; James D Brooks; Matt van de Rijn
Gene expression in the normal adult human kidney assessed by complementary DNA microarray.
Molecular biology of the cell 2004;15(2):649-56.
2004: Hongjuan Zhao; Michael L Whitfield; Tong Xu; David Botstein; James D Brooks
Diverse effects of methylseleninic acid on the transcriptional program of human prostate cancer cells.
Molecular biology of the cell 2004;15(2):506-19.
2004: Jacques Lapointe; Chunde Li; John P Higgins; Matt van de Rijn; Eric Bair; Kelli Montgomery; Michelle Ferrari; Lars Egevad; Walter Rayford; Ulf Bergerheim; Peter Ekman; Angelo M DeMarzo; Robert Tibshirani; David Botstein; Patrick O Brown; James D Brooks; Jonathan R Pollack
Gene expression profiling identifies clinically relevant subtypes of prostate cancer.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(3):811-6.
2003: John P Higgins; Rajesh Shinghal; Harcharan Gill; Jeffrey H Reese; Martha Kennedy Terris; Ronald J Cohen; Michael Fero; Jonathan R Pollack; Matt van de Rijn; James D Brooks
Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray.
The American journal of pathology 2003;162(3):925-32.
2003: Rajesh Shinghal; Cheryl Yemoto; John E McNeal; James D Brooks
Biochemical recurrence without PSA progression characterizes a subset of patients after radical prostatectomy. Prostate-specific antigen.
Urology 2003;61(2):380-5.
2003: Paul-Martin Holterhus; Olaf Hiort; Janos Demeter; Patrick O Brown; James D Brooks
Differential gene-expression patterns in genital fibroblasts of normal males and 46,XY females with androgen insensitivity syndrome: evidence for early programming involving the androgen receptor.
Genome biology 2003;4(6):R37.
2003: John P Higgins; Kelli Montgomery; Lingli Wang; Elizabeth Domanay; Roger A Warnke; James D Brooks; Matt van de Rijn
Expression of FKBP12 in benign and malignant vascular endothelium: an immunohistochemical study on conventional sections and tissue microarrays.
The American journal of surgical pathology 2003;27(1):58-64.
2002: James D Brooks; Michael F Goldberg; Linda A Nelson; David Wu; William G Nelson
Identification of potential prostate cancer preventive agents through induction of quinone reductase in vitro.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(9):868-75.
2002: Atsuko Shibata; Maria Isabel Garcia; Iona Cheng; Thomas A Stamey; John E McNeal; James D Brooks; Stavonnie Henderson; Cheryl E Yemoto; Donna M Peehl
Polymorphisms in the androgen receptor and type II 5 alpha-reductase genes and prostate cancer prognosis.
The Prostate 2002;52(4):269-78.
2002: James D Brooks
Microarray analysis in prostate cancer research.
Current opinion in urology 2002;12(5):395-9.
2002: Samuel E DePrimo; Maximilian Diehn; Joel B Nelson; Robert E Reiter; John Matese; Michael Fero; Robert Tibshirani; Patrick O Brown; James D Brooks
Transcriptional programs activated by exposure of human prostate cancer cells to androgen.
Genome biology 2002;3(7):RESEARCH0032.
2002: Genevieve M Vidanes; Vince Paton; Eric Wallen; Donna M Peehl; Nora Navone; James D Brooks
Silencing of pi-class glutathione S-transferase in MDA PCa 2a and MDA PCa 2b cells.
The Prostate 2002;51(4):225-30.
2002: Steven R Schwarze; Samuel E DePrimo; Lisa M Grabert; Vivian X Fu; James D Brooks; David F Jarrard
Novel pathways associated with bypassing cellular senescence in human prostate epithelial cells.
The Journal of biological chemistry 2002;277(17):14877-83.
2002: James D Brooks; Scott E Eggener; Wen-Min Chao
Anatomy of the rectourethralis muscle.
European urology 2002;41(1):94-100.
2001: James D Brooks; E J Metter; Daniel W Chan; Lori J Sokoll; Patricia Landis; William G Nelson; D Muller; Reubin Andres; H Ballentine Carter
Plasma selenium level before diagnosis and the risk of prostate cancer development.
The Journal of urology 2001;166(6):2034-8.
2001: James D Brooks; V G Paton; Genevieve M Vidanes
Potent induction of phase 2 enzymes in human prostate cells by sulforaphane.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001;10(9):949-54.
2001: Samuel E DePrimo; Rajesh Shinghal; Genevieve M Vidanes; James D Brooks
Prevention of prostate cancer.
Hematology/oncology clinics of North America 2001;15(3):445-57.
2001: J E McNeal; R J Cohen; James D Brooks
Role of cytologic criteria in the histologic diagnosis of Gleason grade 1 prostatic adenocarcinoma.
Human pathology 2001;32(4):441-6.